In the first busy week since the August break, six companies and two SPACs entered the public market. VC-backed health and tech fared well, led by 10x Genomics (TXG) and Cloudflare (NET), while ...read more
SpringWorks Therapeutics, a Phase 3 biotech developing small molecule therapies for rare cancers, raised $162 million by offering 9.0 million shares at $18, the high end of the range of $16 to $18. SpringWorks Therapeutics plans to list on the Nasdaq under...read more
SpringWorks Therapeutics, a Phase 3 biotech developing small molecule therapies for rare cancers, raised the proposed deal size for its upcoming IPO on Thursday. The Stamford, CT-based company now plans to raise $153 million by offering 9 million shares at...read more
After a month-long break, the IPO market is picking up with six deals expected to raise $2.2 billion in the week ahead. Three companies are targeting IPO valuations of $3.5 billion or more. SmileDirectClub (SDC) is the week's largest...read more
US IPO Weekly Recap: Tech and life sciences fare well while SmileDirectClub falls flat in 6-IPO week
In the first busy week since the August break, six companies and two SPACs entered the public market. VC-backed health and tech fared well, led by 10x Genomics (TXG) and Cloudflare (NET), while ...read more
Rare cancer biotech SpringWorks Therapeutics prices IPO at $18 high end
SpringWorks Therapeutics, a Phase 3 biotech developing small molecule therapies for rare cancers, raised $162 million by offering 9.0 million shares at $18, the high end of the range of $16 to $18. SpringWorks Therapeutics plans to list on the Nasdaq under...read more
Rare cancer biotech SpringWorks Therapeutics increases proposed IPO deal size
SpringWorks Therapeutics, a Phase 3 biotech developing small molecule therapies for rare cancers, raised the proposed deal size for its upcoming IPO on Thursday. The Stamford, CT-based company now plans to raise $153 million by offering 9 million shares at...read more
US IPO Week Ahead: IPO market is all smiles with 6 deals including SmileDirectClub
After a month-long break, the IPO market is picking up with six deals expected to raise $2.2 billion in the week ahead. Three companies are targeting IPO valuations of $3.5 billion or more. SmileDirectClub (SDC) is the week's largest...read more